Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer is a research paper published in Frontiers in Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 39 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA177558
NCI NIH HHS
Grant: R01 CA230758
National Institutes of Health
Grant: 1P20GM121327-01
University of Kentucky Center for Cancer and Metabolism
National Institutes of Health
Grant: 5R01CA230758-05
Characterize the role of EBF1 in breast cancer progression
National Institutes of Health
Grant: 3P30CA177558-01S1
CTRP Supplement
National Cancer Institute
National Institutes of Health
American Cancer Society
FWCI
1.49
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals